ASCO: AI Training Improves Accuracy of HER2 Immunohistochemistry Scoring

For HER2 clinical categories, accuracy improved from 66.7 percent without AI to 88.5 percent with AI
genetics breast cancer genes dna
Adobe Stock
Medically Reviewed By:
Farrokh Sohrabi, M.D.
Published on
Updated on
Loading content, please wait...

Related Stories

No stories found.
logo
www.healthday.com